These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9620990)

  • 1. Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.
    Smith PM; Zhang Y; Jennings SR; O'Callaghan DJ
    J Virol; 1998 Jul; 72(7):5366-72. PubMed ID: 9620990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.
    Kim SK; Shakya AK; O'Callaghan DJ
    J Virol; 2016 Sep; 90(18):8090-104. PubMed ID: 27356904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of virus-specific classes of antibodies following immunization of mice with attenuated equine herpesvirus 1 and viral glycoprotein D.
    Zhang Y; Smith PM; Jennings SR; O'Callaghan DJ
    Virology; 2000 Mar; 268(2):482-92. PubMed ID: 10704356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe murine lung immunopathology elicited by the pathogenic equine herpesvirus 1 strain RacL11 correlates with early production of macrophage inflammatory proteins 1alpha, 1beta, and 2 and tumor necrosis factor alpha.
    Smith PM; Zhang Y; Grafton WD; Jennings SR; O'Callaghan DJ
    J Virol; 2000 Nov; 74(21):10034-40. PubMed ID: 11024132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D.
    Zhang Y; Smith PM; Frampton AR; Osterrieder N; Jennings SR; O'Callaghan DJ
    Viral Immunol; 2003; 16(3):307-20. PubMed ID: 14583146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1.
    Allen G; Yeargan M; Costa LR; Cross R
    J Virol; 1995 Jan; 69(1):606-12. PubMed ID: 7983765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model.
    Azmi M; Field HJ
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2339-45. PubMed ID: 8245851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.
    Smith PM; Kahan SM; Rorex CB; von Einem J; Osterrieder N; O'Callaghan DJ
    J Virol; 2005 Apr; 79(8):5105-15. PubMed ID: 15795295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH; Wattrang E; Hannant D
    Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL.
    Colle CF; Tarbet EB; Grafton WD; Jennings SR; O'Callaghan DJ
    Virus Res; 1996 Aug; 43(2):111-24. PubMed ID: 8864201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.
    von Einem J; Wellington J; Whalley JM; Osterrieder K; O'Callaghan DJ; Osterrieder N
    J Virol; 2004 Mar; 78(6):3003-13. PubMed ID: 14990719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice.
    Alber DG; Greensill J; Killington RA; Stokes A
    Res Vet Sci; 1995 Nov; 59(3):205-13. PubMed ID: 8588092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model.
    Frampton AR; Smith PM; Zhang Y; Matsumura T; Osterrieder N; O'Callaghan DJ
    Virus Res; 2002 Dec; 90(1-2):287-301. PubMed ID: 12457983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1.
    Kydd JH; Davis-Poynter NJ; Birch J; Hannant D; Minke J; Audonnet JC; Antczak DF; Ellis SA
    J Gen Virol; 2006 Sep; 87(Pt 9):2507-2515. PubMed ID: 16894188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.
    Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N
    Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.
    Jennings SR; Bonneau RH; Smith PM; Wolcott RM; Chervenak R
    Cell Immunol; 1991 Mar; 133(1):234-52. PubMed ID: 1671342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
    Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
    Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD.
    Zhang Y; Smith PM; Tarbet EB; Osterrieder N; Jennings SR; O'Callaghan DJ
    Virus Res; 1998 Jul; 56(1):11-24. PubMed ID: 9784062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
    Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
    J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.